Clinical Trial Update: A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 trial evaluating the safety and dosimetry of the radiopharmaceutical 68Ga-OncoACP3 in patients with prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-OncoACP3 (Ga-68-OncoACP3)

Snippet

Sponsor: Philogen S.p.A. | Conditions: Prostate Cancer, Prostate Cancer Metastatic Disease | Phase 1 | Status: COMPLETED